Are you Dr. Phelan?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
You already have 71 invites waiting! - Read the latest clinical news, personalized to your specialty.
Office
2160 S 1st Ave
Cardinal Bernardin Cancer Center
Maywood, IL 60153Phone+1 708-216-9000
Summary
- Dr. Kathleen (Wren) Phelan, MD is an oncologist in Maywood, Illinois. She is currently licensed to practice medicine in Illinois. She is affiliated with Loyola University Medical Center and Edward Hines, Jr. Veterans Affairs Hospital.
Education & Training
Loyola University Medical CenterFellowship, Hematology and Medical Oncology, 2009 - 2012- Loyola University Medical CenterResidency, Internal Medicine, 2005 - 2009
Chicago Medical School at Rosalind Franklin University of Medicine and ScienceClass of 2005
Certifications & Licensure
IL State Medical License 2008 - 2026- American Board of Internal Medicine Hematology
- American Board of Internal Medicine Medical Oncology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2013
Clinical Trials
- Cytarabine and Daunorubicin Hydrochloride or Idarubicin and Cytarabine With or Without Vorinostat in Treating Younger Patients With Previously Untreated Acute Myeloid Leukemia Start of enrollment: 2013 Feb 12
- Rituximab and Bendamustine Hydrochloride, Rituximab and Ibrutinib, or Ibrutinib Alone in Treating Older Patients With Previously Untreated Chronic Lymphocytic Leukemia Start of enrollment: 2013 Dec 09
- Clofarabine or Daunorubicin Hydrochloride and Cytarabine Followed By Decitabine or Observation in Treating Older Patients With Newly Diagnosed Acute Myeloid Leukemia Start of enrollment: 2011 Feb 04
Publications & Presentations
PubMed
- 27 citationsNovel Therapies in Acute Lymphoblastic Leukemia.Kathleen Wren Phelan, Anjali S. Advani
Current Hematologic Malignancy Reports. 2018-08-01 - 9 citationsAssociation between early promoter-specific DNA methylation changes and outcome in older acute myeloid leukemia patientsNicholas J. Achille, Megan Othus, Kathleen Wren Phelan, Shubin Zhang, Kathrine A. Cooper
Leukemia Research. 2016-03-01 - COVID-19 thromboembolism incidence, risk factors, and anticoagulation practices from a Chicago metropolitan US population.Stephanie Berg, Seo-Hyun Kim, Amy Wozniak, Oluwatobi Odetola, Saad Arain
American Journal of Hematology. 2022-06-01
